YoungInnovation

updated on July 11, 2024

Special Event I

YoungInnovation
The State of Research communicated by Young Researchers

September 11-12-13

Chairs:
Marco ROSSI, Sapienza University of Rome
Donatella PAOLINO, University Magna Graecia of Catanzaro

SCIENTIFIC COMMITTEE:
Marzia QUAGLIO, Polytechnic University of Turin
Giuliana FAGGIO & Giacomo MESSINA, The “Mediterranean” University of Reggio Calabria

ORGANIZING BOARD:
Francesca RISPLENDI, Polytechnic University of Turin
Alessia BRAMANTI, University of Salerno
Michele CONTI, University of Pavia

Co-organized with

Researchers have always played a fundamental role in finding solutions to complex challenges. For this reason, NanoInnovation is committed to encouraging and facilitating the participation of young researchers (under 35 years of age) in the scientific world and supporting their careers through mentoring activities. In line with these objectives, Young Innovation has evolved into a semi-independent event, now in its fourth edition, to be held from 11 to 13 September 2024, increasingly enriched with significant presences and aimed at the researchers of the future.

Young Innovation has become a well-defined event consisting of three days of discussions, divided into 90-minute sessions. In particular, the sessions will be developed to include:

1. Parallel sessions focusing on the macro areas of Material Sciences and Life Sciences.

2. Other sessions covering topics common to both the above macro areas.

Each Young Innovation session will include:

Introductory talk (max 30 min) on the state-of-the-art of the session theme by a senior researcher;
4 contributions (max 7 min/each) by young researchers, presenting the results of their current studies;
A short concluding round table discussion (approx. 30 min) with questions and answers between young researchers and senior researchers.

The specific topics of the event will be selected by the Chairs and the NanoInnovation Organizing Committee, who will also appoint the members of the Young Innovation Scientific Committee and the Organizing Committee.

As for the young speakers interested in participating, the spontaneous application requires:

1. the uploading of the abstract of their research through the website, on the dedicated submission section CALL FOR POSTERS.

2. the ticking the ‘Young Innovation” box during the submission.

Selected abstracts from the under-35 applicants, based on the quality of the proposed research and its relevance to the theme of the session, will be invited to present during Young Innovation and could be displayed in printed form during Nanoinnovation and uploaded on the website in the dedicated session.

Selected participants will not have to pay the submission fee required for the regular poster session. Those not selected for the event can still pay the fee and participate by uploading their poster to the website and displaying it during the event.

Overall, the purpose of the Young Innovation event is to provide a platform for these emerging scientists to share their research and network with colleagues at the event. As such, the event serves not only as a showcase for cutting-edge research, but also as a catalyst for collaboration, inspiration and the advancement of scientific knowledge.

September 11

09:00 - 10:30
Next-generation semiconductor devices for power electronics applications
SE.I.1- TT.I.H

in cooperation with

Chair: to be defìned

The session will delve into the forefront of semiconductor technology, showcasing innovative advancements that are set to revolutionize the field of power electronics. This session will bring together experts to discuss the latest developments in semiconductor materials, device architectures, and fabrication techniques. This session aims to foster collaboration and knowledge exchange, providing a platform for discussing the future directions of semiconductor technology in power electronics. Participants will leave with a comprehensive understanding of how next-generation semiconductor devices are poised to drive innovation and efficiency in power electronics applications.

SE.I.1.1
TT.I.H.1

Introductive Keynote
Filippo GIANNAZZO - CV
CNR-IMM
New devices based on 2D materials integrated on wide-bandgap semiconductors

SE.I.1.2
TT.I.H.2

to be defìned

SE.I.1.3
TT.I.H.3

to be defìned

SE.I.1.4
TT.I.H.4

to be defìned

SE.I.1.5
TT.I.H.5

to be defìned

Round table on the Topic

09:00 - 10:30
Artificial intelligence and Machine learning in digital health
SE.I.2 - TT.I.I

Chair: Alessia BRAMANTI, University of Salerno

The evolution of digital technologies is opening new frontiers in healthcare, thanks to the integration of Artificial Intelligence (AI) and Machine Learning. These powerful technologies are tackling complex medical challenges and transforming the healthcare field into a new era of more accurate diagnoses, personalized therapies, and proactive health management. From early disease detection to individual risk prediction, these technologies are proving to be fundamental tools for enhancing the precision and effectiveness of treatments. In detail, AI is revolutionizing the collection and analysis of clinical data, enabling the identification of hidden patterns and correlations that would escape human observation. On the other hand, Machine Learning is refining predictions of medical outcomes and facilitating continuous patient monitoring through digital devices and wearables. The link between AI, Machine Learning, and Digital Health not only promises improvements in timely diagnoses and prognosis, but also offers innovative solutions for managing large volumes of medical data, discovering new drugs, and personalized therapies. However, this revolution is not without challenges, such as ethical dilemmas related to patient data usage and the implementation of decision-making algorithms in healthcare. Balancing technological innovation with privacy and medical responsibility is a crucial theme that requires attention.

SE.I.2.1
TT.I.I.1

Introductive Keynote
Speaker to be defined
Application of artificial intelligence and machine learning in cardiovascular diseases

SE.I.2.2
TT.I.I.2

to be defìned

SE.I.2.3
TT.I.I.3

to be defìned

SE.I.2.4
TT.I.I.4

to be defìned

SE.I.2.5
TT.I.I.5

to be defìned

Round table on the Topic

11:30 - 13:00
Bioengineering for biomedical applications of microfluidics
SE.I.3 - TT.II.H

Chair: to be defined

The session will provide an overwiew about the use of microfluidic techniques, enabling innovative biomedical applications, discussing new methological approaches to supprt the device design, as well.

SE.I.3.1
TT.II.H.1

Introductive Keynote
Pier Luca MAFFETTONE
University of Naples "Federico II"
Micro-particle manipulation in microfluidic with viscoelastic liquidis

SE.I.3.2
TT.II.H.2

to be defìned

SE.I.3.3
TT.II.H.3

to be defìned

SE.I.3.4
TT.II.H.4

to be defìned

SE.I.3.5
TT.II.H.5

to be defìned

Round table on the Topic

11:30 - 13:00
Title to be defined
SE.I.4 - TT.II.I

Chair: to be defined

SE.I.4.1
TT.II.I.1

Introductive Keynote
to be defìned

SE.I.4.2
TT.II.I.2

to be defìned

SE.I.4.3
TT.II.I.3

to be defìned

SE.I.4.4
TT.II.I.4

to be defìned

SE.I.4.5
TT.II.I.5

to be defìned

Round table on the Topic

14:00 - 15:30
Regenerative medicine: current applications, challenges and future directions
SE.I.5 - TT.III.H

Chair: to be defined

Regenerative medicine represents a beacon of hope in modern healthcare, promising solutions for degenerative diseases and tissue damage. This session delves into the multifaceted landscape of regenerative medicine, charting its present achievements, grappling with existing obstacles, and envisioning the bold trajectories that lie ahead. Current applications of regenerative medicine span a diverse spectrum, from stem cell therapies to tissue-engineered constructs fostering organ regeneration. These breakthroughs underscore the potential to mend the human body at its most fundamental level, encouraging natural healing processes to restore vitality. However, the path to full realization is not without hurdles. The challenges of immune rejection, ethical considerations, and ensuring safe, standardized protocols demand careful exploration. Looking forward, regenerative medicine holds the promise of tailored treatments, personalized to an individual's genetic makeup and medical history. Innovations such as organ printing, gene editing, and bioactive scaffolds are poised to redefine healthcare paradigms, bridging the gap between science fiction and tangible medical solutions.

SE.I.5.1 TT.III.H.1

Introductive Keynote
Fiorica CALOGERO
University of Palermo
Development and characterization of polymeric biomaterilas for regenerative medicine application

SE.I.5.2 TT.III.H2

to be defìned

SE.I.5.3 TT.III.H.3

to be defìned

SE.I.5.4 TT.III.H.4

to be defìned

SE.I.5.5 TT.III.H.5

to be defìned

Round table on the Topic

14:00 - 15:30
Title to be defined
SE.I.6 - TT.III.I

Chair: to be defined

SE.I.6.1 TT.III.I.1

Introductive Keynote
to be defìned

SE.I.6.2 TT.III.I.2

to be defìned

SE.I.6.3 TT.III.I.3

to be defìned

SE.I.6.4 TT.III.I.4

to be defìned

SE.I.6.5 TT.III.I.5

to be defìned

Round table on the Topic

16:00 - 17:30
Nanotechnologies for precision medicine
SE.I.7 - TT.IV.H

Chair: to be defined

SE.I.7.1
TT.IV.H.1

Introductive Keynote
Marco MONOPOLI
Royal College of Surgeons, Ireland | European Technology Platform on Nanomedicine (ETPN Association)
Title to be defined

SE.I.7.2
TT.IV.H.2

to be defìned

SE.I.7.3
TT.IV.H.3

to be defìned

SE.I.7.4
TT.IV.H.4

to be defìned

SE.I.7.5
TT.IV.H.5

to be defìned

Round table on the Topic

16:00 - 17:30
Title to be defined
SE.I.8 - TT.IV.I

Chair: to be defined

SE.I.8.1 TT.IV.I.1

Introductive Keynote
to be defìned

SE.I.8.2 TT.IV.I.2

to be defìned

SE.I.8.3 TT.IV.I.3

to be defìned

SE.I.8.4 TT.IV.I.4

to be defìned

SE.I.8.5 TT.IV.I.5

to be defìned

Round table on the Topic

17:45 - 19:15
Title to be defined
BO.1.A

Chair: to be defined

BO.1.A.1

to be defìned

17:30 - 20:00
Cocktail & Social

September 12

09:00 - 10:30
Nanotherapeutic in unmet clinical need
SE.I.9- TT.V.H

Chair: to be defìned

SE.I.9.1
TT.V.H.1

Introductive Keynote
Alexandre CECCALDI
European Technology Platform for Nanomedicine (ETPN)
Title to be defined

SE.I.9.2
TT.V.H.2

to be defìned

SE.I.9.3
TT.V.H.3

to be defìned

SE.I.9.4
TT.V.H.4

to be defìned

SE.I.9.5
TT.V.H.5

to be defìned

Round table on the Topic

09:00 - 10:30
Title to be defined
SE.I.10 - TT.V.I

Chair: to be defined

SE.I.10.1
TT.I.V.I.1

Introductive Keynote
to be defìned

SE.I.10.2
TT.I.V.I.2

to be defìned

SE.I.10.3
TT.I.V.I.3

to be defìned

SE.I.10.4
TT.I.V.I.4

to be defìned

SE.I.10.5
TT.I.V.I.5

to be defìned

Round table on the Topic

11:30 - 13:00
Hybrid and Composite nanomaterials for energy
SE.I.11 - TT.VI.H

in cooperation with

Chair: to be defined

The session will explore the cutting-edge advancements and applications of nanomaterials in the energy sector. This session aims to highlight the unique properties and potential of hybrid and composite nanomaterials in addressing the global energy challenges. The session will cover a wide range of topics, including the development of novel nanocomposites for energy storage, conversion, and harvesting applications. Attendees will gain insights into the challenges and opportunities in the fabrication and scalability of these advanced materials. Discussions will also address the environmental impact and sustainability of nanomaterial-based energy solutions.

SE.I.11.1
TT.VI.H.1

Introductive Keynote
Pietro CATALDI
IIT
Multifunctional and Sustainable hybrid and nanocomposite materials for electronics, sensors and energy

SE.I.11.2
TT.VI.H.2

to be defìned

SE.I.11.3
TT.VI.H.3

to be defìned

SE.I.11.4
TT.VI.H.4

to be defìned

SE.I.11.5
TT.VI.H.5

to be defìned

Round table on the Topic

11:30 - 13:00
Preclinical, Clinical and Industrial Transfer
SE.I.12 - TT.VI.I

Chair: to be defined

This session delves into the dynamic landscape of advanced models for precision medicine, illuminating their role in reshaping the future of healthcare. With a focus on individualized treatment approaches, these models integrate cutting-edge technologies to deliver tailored solutions that revolutionize patient care. Precision medicine harnesses genetic, molecular, and clinical data to customize treatments for individuals. As the horizon unfurls, advanced models hold transformative potential. From rare diseases to chronic conditions, precision medicine pioneers tailored treatments, improving patient outcomes and minimizing adverse effects. This evolving paradigm not only redefines patient care but also drives innovations across healthcare systems. This session portrays the dynamic journey of advanced models for precision medicine, spotlighting their ability to reshape medical practice, foster breakthroughs, and lead us into an era of truly individualized healthcare.

SE.I.12.1
TT.VI.I.1

Introductive Keynote
Marzia BEDONI
Don Gnocchi Foundation
Title to be defined

SE.I.12.2
TT.VI.I.2

to be defìned

SE.I.12.3
TT.VI.I.3

to be defìned

SE.I.12.4
TT.VI.I.4

to be defìned

SE.I.12.5
TT.VI.I.5

to be defìned

Round table on the Topic

14:00 - 15:30
Photochemistry and Photophysics in energy conversion
SE.I.13 - TT.VII.H

in cooperation with

Chair: to be defined

The session "Photochemistry and Photophysics in Energy Conversion" will delve into the pivotal roles that photochemical and photophysical processes play in modern energy conversion technologies. Speakers will address the latest breakthroughs in photophysical phenomena, such as exciton dynamics, charge transfer, and energy transfer processes, and how these insights are being harnessed to improve the performance of energy conversion devices. Discussions will also encompass the role of nanostructured materials, organic and inorganic semiconductors, and hybrid systems in optimizing light absorption and conversion efficiency. Attendees will gain a comprehensive understanding of the theoretical and practical aspects of photochemistry and photophysics in the context of energy conversion. The session aims to foster interdisciplinary collaboration, encouraging the exchange of ideas and the development of innovative solutions to enhance the sustainability and efficiency of energy systems.

SE.I.13.1
TT.VII.H.1

Introductive Keynote
Giacomo BERGAMINI
University of Bologna
Photoactive materials and techniques for energy conversion

SE.I.13.2
TT.VII.H.2

to be defìned

SE.I.13.3
TT.VII.H.3

to be defìned

SE.I.13.4
TT.VII.H.4

to be defìned

SE.I.13.5
TT.VII.H.5

to be defìned

Round table on the Topic

14:00 - 15:30
Exploring the Future: Advances in 3D Bioprinting for Tissue Engineering and Regenerative Medicine
SE.I.14 - TT.VII.I

Chair: Carmine GENTILE, University of Pavia

This revolutionary technique allows for the precise printing of cells, biocompatible materials, scaffolds or support structures, and growth factors promoting cell growth and the formation of new tissues or organs. The primary goal of 3D-bioprinting is to address the growing shortage of organs for transplantation and find solutions for tissue repair. The advantages of 3D-Bioprinting applied to medicine and research fields are numerous, such as the possibility to obtain a personalized therapy creating tissues that mimic a patient's unique biology and creating patient-specific tissues and organs, tailored to individual needs; the disease modeling for a deeper understanding of disease mechanisms and the development of more effective treatments or to study rare and complex diseases that are challenging to replicate in traditional cell cultures, providing insights into their underlying mechanisms; moreover bioprinted tissues can serve as alternatives to animal testing, reducing the ethical concerns associated with animal experimentation while providing more relevant data for human health. Despite these and other advantages, there are significant challenges to overcome, such as the complexity of biological structures and the need to develop biocompatible and safe materials for use in 3D-bioprinting. Nevertheless, the field of 3D-bioprinting is rapidly evolving, with researchers and companies working to refine the technology and move it from experimental phases to practical applications in medicine and science.

SE.I.14.1
TT.VII.I.1

Introductive Keynote
Michele CONTI
University of Pavia
Title to be defined

SE.I.14.2
TT.VII.I.2

to be defìned

SE.I.14.3
TT.VII.I.3

to be defìned

SE.I.14.4
TT.VII.I.4

to be defìned

SE.I.14.5
TT.VII.I.5

to be defìned

Round table on the Topic

16:00 - 17:30
Nanomaterials for catalytic processes
SE.I.15 - TT.VIII.H

in cooperation with

Chair: to be defined

The session "Nanomaterials for Catalytic Processes" will explore the transformative impact of nanomaterials on the field of catalysis, highlighting their unique properties and applications in various catalytic processes. Attendees will gain insights into the mechanisms by which nanomaterials facilitate catalytic processes, including their surface properties, electronic structures, and interaction with reactants. The session will also delve into the practical applications of nanocatalysts in areas such as chemical synthesis, environmental remediation, energy conversion, and industrial processes.

SE.I.15.1
TT.VIII.H.1

Introductive Keynote
Giuseppina LUCIANI
University of Naples "Federico II"
Nanocatalysts for sustainable energy and environment

SE.I.15.2
TT.VIII.H.2

to be defìned

SE.I.15.3
TT.VIII.H.3

to be defìned

SE.I.15.4
TT.VIII.H.4

to be defìned

SE.I.15.5
TT.VIII.H.5

to be defìned

Round table on the Topic

16:00 - 17:30
Characterization of nanomaterials
SE.I.16 - TT.VIII.I

Chair: to be defined

SE.I.16.1
TT.VIII.I.1

Introductive Keynote
L. CALZOLAI
ISPRA
Title to be defined

SE.I.16.2
TT.VIII.I.2

to be defìned

SE.I.16.3
TT.VIII.I.3

to be defìned

SE.I.16.4
TT.VIII.I.4

to be defìned

SE.I.16.5
TT.VIII.I.5

to be defìned

Round table on the Topic

17:45 - 19:15
Title to be defined
BO.2.A

Chair: to be defined

BO.2.A.1

Annukka SANTASALO-AARNIO
Circular Economy Approaches in the Field of Materials for Energy

17:30 - 20:00
Cocktail & Social

September 13

09:00 - 10:30
Title to be defined
SE.I.17- TT.IX.H

Chair: to be defìned

SE.I.17.1
TT.IX.H.1

Introductive Keynote
to be defìned

SE.I.17.2
TT.IX.H.2

to be defìned

SE.I.17.3
TT.IX.H.3

to be defìned

SE.I.17.4
TT.IX.H.4

to be defìned

SE.I.17.5
TT.IX.H.5

to be defìned

Round table on the Topic

09:00 - 10:30
Biomaterials
SE.I.18 - TT.IX.I

Chair: to be defined

SE.I.18.1
TT.IX.I.1

Introductive Keynote
Francesco PUOCI
University of Calabria
Title to be defined

SE.I.18.2
TT.IX.I.2

to be defìned

SE.I.18.3
TT.IX.I.3

to be defìned

SE.I.18.4
TT.IX.I.4

to be defìned

SE.I.18.5
TT.IX.I.5

to be defìned

Round table on the Topic

11:30 - 13:00
Optical and Acoustic trapping
SE.I.19 - TT.X.H

Chairs: Giuliana FAGGIO & Giacomo MESSINA, Mediterranean University of Reggio Calabria

SE.I.19.1
TT.X.H.1

Introductive Keynote
Maria Grazia DONATO
CNR- IPFC
Optical and Acoustic trapping for characterization of materials

SE.I.19.2
TT.X.H.2

to be defìned

SE.I.19.3
TT.X.H.3

to be defìned

SE.I.19.4
TT.X.H.4

to be defìned

SE.I.19.5
TT.X.H.5

to be defìned

Round table on the Topic

11:30 - 13:00
Gene and Biotech Delivery
SE.I.20 - TT.X.I

Chair: to be defined

SE.I.20.1
TT.X.I.1

Introductive Keynote
Fabiana QUAGLIA
University of Naples "Federico II"
Title to be defined

SE.I.20.2
TT.X.I.2

to be defìned

SE.I.20.3
TT.X.I.3

to be defìned

SE.I.20.4
TT.X.I.4

to be defìned

SE.I.20.5
TT.X.I.5

to be defìned

Round table on the Topic

14:00 - 15:30
H2 technologies and CO₂ reduction
SE.I.21 - TT.XI.H

Chair: Francesca RISPLENDI, Polytechnic University of Turin

SE.I.21.1
TT.XI.H.1

Introductive Keynote
to be defìned

SE.I.21.2
TT.XI.H.2

to be defìned

SE.I.21.3
TT.XI.H.3

to be defìned

SE.I.21.4
TT.XI.H.4

to be defìned

SE.I.21.5
TT.XI.H.5

to be defìned

Round table on the Topic

14:00 - 15:30
Tumor microenvironment on the move: progress and challenges
SE.I.22 - TT.XI.I

Chair: to be defined

Deepening the tumor microenvironment, a complex interplay of cells, signals, and structures, holds the key to unraveling cancer progression and devising targeted therapies. Cellular interactions, immune responses, and extracellular matrix dynamics converge to influence tumor growth and metastasis. Advances in imaging and single-cell analysis provide unprecedented glimpses into this dynamic landscape, paving the way for tailored interventions. However, challenges loom large. The heterogeneous nature of the microenvironment and its adaptive responses pose obstacles to effective treatments. Therapeutic resistance, immune evasion, and the intricate web of interactions demand innovative strategies. As researchers and clinicians navigate this intricate terrain, novel avenues emerge. Targeted therapies, immunomodulation, and precision medicine strategies are being tailored to exploit the vulnerabilities within the tumor microenvironment. Collaborative efforts bridge disciplines, fostering breakthroughs in understanding and interventions. In the quest for progress, the tumor microenvironment offers untold potential. A deeper comprehension promises to usher in an era of personalized treatments, potent combination therapies, and improved patient outcomes, redefining the battle against cancer. Here, the evolving journey through the tumor microenvironment is captured, highlighting progress, acknowledging challenges, and illuminating a trajectory that merges science, technology, and compassion to transform the landscape of cancer care.

SE.I.22.1 TT.XI.I.1

Introductive Keynote
Ines BARONE & Daniela BONOFIGLIO
University of Calabria
Title to be defined

SE.I.22.2 TT.XI.I.2

to be defìned

SE.I.22.3 TT.XI.I.3

to be defìned

SE.I.22.4 TT.XI.I.4

to be defìned

SE.I.22.5 TT.XI.I.5

to be defìned

Round table on the Topic

16:00 - 17:30
Cryo-Tem
SE.I.23 - TT.XII.H

Chair: Marco ROSSI, Sapienza University of Rome

SE.I.23.1
TT.XII.I.1

Introductive Keynote
to be defìned

SE.I.23.2
TT.XII.I.2

to be defìned

SE.I.23.3
TT.XII.I.3

to be defìned

SE.I.23.4
TT.XII.I.4

to be defìned

SE.I.23.5
TT.XII.I.5

to be defìned

Round table on the Topic

16:00 - 17:30
Title to be defined
SE.I.24 - TT.XII.I

Chair: to be defined

SE.I.24.1 TT.XII.I.1

Introductive Keynote
to be defìned

SE.I.24.2 TT.XII.I.2

to be defìned

SE.I.24.3 TT.XII.I.3

to be defìned

SE.I.24.4 TT.XII.I.4

to be defìned

SE.I.24.5 TT.XII.I.5

to be defìned

Round table on the Topic

17:45 - 19:15
Title to be defined
BO.3.A

Chair: to be defined

BO.3.A.1

to be defìned

17:30 - 20:00
Cocktail & Social

Sapienza University of Rome

D3 4 Health

iENTRANCE

Polytechnic University of Turin

University of Modena and Reggio Emilia

The "Mediterranean" University of Reggio Calabria

University of Milan

ROMA TRE University

ENEA

Bruno Kessler Foundation

INAIL

INRIM

Istituto Superiore di Sanità

GAMBETTI KENOLOGIA

JEOL (ITALIA) S.p.A.

Media System Lab S.r.l.

Scuola Normale Superiore

DON GNOCCHI FOUNDATION

ZEISS

YoungInnovation

WHAT - HOW - WHERE

NANO NEWS

.

INFO & CONTACTS